Most lately, it's been discovered that conolidine and the above mentioned derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in similar regions as classical opioid receptors, it binds into a big selection of endogenous opioids. Not like most opioid receptors, this receptor acts to be a scavenger https://benjaminr703jqv4.win-blog.com/profile